| 标题 |
[求助补充材料]
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Swaminathan P. Iyer; R. Alejandro Sica; P. Joy Ho; Anca Prica; Jasmine M. Zain; et al 出版日期:2024-11-28 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)